Form 4: Amneal Pharmaceuticals Director Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


Director Deborah M. Autor sold shares of Amneal Pharmaceuticals to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

  • On May 16, 2024, Deborah M. Autor, a director of Amneal Pharmaceuticals, sold 14,553 shares of Class A Common Stock at a weighted average price of $6.76.
  • The shares were sold in multiple transactions with prices ranging from $6.75 to $6.79 per share.
  • Following this transaction, Ms. Autor directly owned 116,849 shares.
  • On May 17, 2024, Ms. Autor sold 23,447 shares of Class A Common Stock at a weighted average price of $6.727.
  • These shares were sold in multiple transactions with prices ranging from $6.70 to $6.77 per share.
  • Following this transaction, Ms. Autor directly owned 93,402 shares.
  • The sales were executed to cover tax withholding obligations related to the vesting of restricted stock units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports the sale of shares by a director to cover tax obligations, which is a routine transaction.

Industry Context

Insider sales are a common occurrence and are often related to personal financial planning or tax obligations. It's important to consider the context of these sales, such as the overall trading activity and the company's performance.

Stakeholder Impact

  • The sale of shares by a director could have a minor impact on shareholder sentiment, but is unlikely to have a significant long-term effect given the reason for the sale.

Key Dates

DateDescription
05/16/2024Deborah M. Autor sold 14,553 shares of Class A Common Stock.
05/17/2024Deborah M. Autor sold 23,447 shares of Class A Common Stock.
05/20/2024Date of signature by Attorney-in-Fact, Denis Butkovic.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.